| John Kelleher, MD | |
|
30 Hope Dr, Hershey, PA 17033-2036 | |
| (717) 531-3828 | |
| (717) 531-0793 |
| Full Name | John Kelleher |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 18 Years |
| Location | 30 Hope Dr, Hershey, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609082072 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | MD438056 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Milton S Hershey Medical Center | Hershey, PA | Hospital |
| Reading Hospital | West reading, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Milton S Hershey Medical Center Physicians Group | 3870405483 | 1400 |
| Tower Health Medical Group | 7618889213 | 577 |
News Archive
Gilead Sciences, Inc. today announced that the European Commission has granted marketing authorization for Sovaldi (sofosbuvir) 400 mg tablets, a once-daily oral nucleotide analogue polymerase inhibitor for the treatment of chronic hepatitis C infection in adults, in combination with other antiviral agents (ribavirin and pegylated interferon alpha (peg-IFN)).
A landmark work that details the strengths and weaknesses of the U.S. health insurance system, including how it lags behind those of other wealthy countries in measures that include mortality from both preventable and treatable causes, has been published.
Abortion is one of the hottest political issues of 2019. With a newly configured Supreme Court, which many pundits think has the votes to roll back or overturn the landmark 1972 Roe v. Wade ruling, states are rushing either to protect abortion rights or pass laws intended to restrict or ban it.
Moderate to severe chronic liver disease can be predicted with the use of diffusion-weighted MRI (DWI), according to a recent study conducted by researchers at New York University Medical Center in New York, NY.
Older adults with type 1 diabetes typically have low blood sugar, or hypoglycemia, for more than an hour a day, suggests research to be presented Monday, March 25 at ENDO 2019, the annual meeting of the Endocrine Society, in New Orleans, La.
› Verified 6 days ago
| Entity Name | The Milton S Hershey Medical Center Physicians Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710951744 PECOS PAC ID: 3870405483 Enrollment ID: O20040225000741 |
News Archive
Gilead Sciences, Inc. today announced that the European Commission has granted marketing authorization for Sovaldi (sofosbuvir) 400 mg tablets, a once-daily oral nucleotide analogue polymerase inhibitor for the treatment of chronic hepatitis C infection in adults, in combination with other antiviral agents (ribavirin and pegylated interferon alpha (peg-IFN)).
A landmark work that details the strengths and weaknesses of the U.S. health insurance system, including how it lags behind those of other wealthy countries in measures that include mortality from both preventable and treatable causes, has been published.
Abortion is one of the hottest political issues of 2019. With a newly configured Supreme Court, which many pundits think has the votes to roll back or overturn the landmark 1972 Roe v. Wade ruling, states are rushing either to protect abortion rights or pass laws intended to restrict or ban it.
Moderate to severe chronic liver disease can be predicted with the use of diffusion-weighted MRI (DWI), according to a recent study conducted by researchers at New York University Medical Center in New York, NY.
Older adults with type 1 diabetes typically have low blood sugar, or hypoglycemia, for more than an hour a day, suggests research to be presented Monday, March 25 at ENDO 2019, the annual meeting of the Endocrine Society, in New Orleans, La.
› Verified 6 days ago
| Entity Name | Tower Health Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609291350 PECOS PAC ID: 7618889213 Enrollment ID: O20040311000072 |
News Archive
Gilead Sciences, Inc. today announced that the European Commission has granted marketing authorization for Sovaldi (sofosbuvir) 400 mg tablets, a once-daily oral nucleotide analogue polymerase inhibitor for the treatment of chronic hepatitis C infection in adults, in combination with other antiviral agents (ribavirin and pegylated interferon alpha (peg-IFN)).
A landmark work that details the strengths and weaknesses of the U.S. health insurance system, including how it lags behind those of other wealthy countries in measures that include mortality from both preventable and treatable causes, has been published.
Abortion is one of the hottest political issues of 2019. With a newly configured Supreme Court, which many pundits think has the votes to roll back or overturn the landmark 1972 Roe v. Wade ruling, states are rushing either to protect abortion rights or pass laws intended to restrict or ban it.
Moderate to severe chronic liver disease can be predicted with the use of diffusion-weighted MRI (DWI), according to a recent study conducted by researchers at New York University Medical Center in New York, NY.
Older adults with type 1 diabetes typically have low blood sugar, or hypoglycemia, for more than an hour a day, suggests research to be presented Monday, March 25 at ENDO 2019, the annual meeting of the Endocrine Society, in New Orleans, La.
› Verified 6 days ago
| Entity Name | Spirit Physician Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093013328 PECOS PAC ID: 8022922202 Enrollment ID: O20040402000053 |
News Archive
Gilead Sciences, Inc. today announced that the European Commission has granted marketing authorization for Sovaldi (sofosbuvir) 400 mg tablets, a once-daily oral nucleotide analogue polymerase inhibitor for the treatment of chronic hepatitis C infection in adults, in combination with other antiviral agents (ribavirin and pegylated interferon alpha (peg-IFN)).
A landmark work that details the strengths and weaknesses of the U.S. health insurance system, including how it lags behind those of other wealthy countries in measures that include mortality from both preventable and treatable causes, has been published.
Abortion is one of the hottest political issues of 2019. With a newly configured Supreme Court, which many pundits think has the votes to roll back or overturn the landmark 1972 Roe v. Wade ruling, states are rushing either to protect abortion rights or pass laws intended to restrict or ban it.
Moderate to severe chronic liver disease can be predicted with the use of diffusion-weighted MRI (DWI), according to a recent study conducted by researchers at New York University Medical Center in New York, NY.
Older adults with type 1 diabetes typically have low blood sugar, or hypoglycemia, for more than an hour a day, suggests research to be presented Monday, March 25 at ENDO 2019, the annual meeting of the Endocrine Society, in New Orleans, La.
› Verified 6 days ago
| Entity Name | Penn State Health Community Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861988644 PECOS PAC ID: 8729351077 Enrollment ID: O20170907002279 |
News Archive
Gilead Sciences, Inc. today announced that the European Commission has granted marketing authorization for Sovaldi (sofosbuvir) 400 mg tablets, a once-daily oral nucleotide analogue polymerase inhibitor for the treatment of chronic hepatitis C infection in adults, in combination with other antiviral agents (ribavirin and pegylated interferon alpha (peg-IFN)).
A landmark work that details the strengths and weaknesses of the U.S. health insurance system, including how it lags behind those of other wealthy countries in measures that include mortality from both preventable and treatable causes, has been published.
Abortion is one of the hottest political issues of 2019. With a newly configured Supreme Court, which many pundits think has the votes to roll back or overturn the landmark 1972 Roe v. Wade ruling, states are rushing either to protect abortion rights or pass laws intended to restrict or ban it.
Moderate to severe chronic liver disease can be predicted with the use of diffusion-weighted MRI (DWI), according to a recent study conducted by researchers at New York University Medical Center in New York, NY.
Older adults with type 1 diabetes typically have low blood sugar, or hypoglycemia, for more than an hour a day, suggests research to be presented Monday, March 25 at ENDO 2019, the annual meeting of the Endocrine Society, in New Orleans, La.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John Kelleher, MD 500 University Dr, H088, Hershey, PA 17033-2360 Ph: (717) 531-1692 | John Kelleher, MD 30 Hope Dr, Hershey, PA 17033-2036 Ph: (717) 531-3828 |
News Archive
Gilead Sciences, Inc. today announced that the European Commission has granted marketing authorization for Sovaldi (sofosbuvir) 400 mg tablets, a once-daily oral nucleotide analogue polymerase inhibitor for the treatment of chronic hepatitis C infection in adults, in combination with other antiviral agents (ribavirin and pegylated interferon alpha (peg-IFN)).
A landmark work that details the strengths and weaknesses of the U.S. health insurance system, including how it lags behind those of other wealthy countries in measures that include mortality from both preventable and treatable causes, has been published.
Abortion is one of the hottest political issues of 2019. With a newly configured Supreme Court, which many pundits think has the votes to roll back or overturn the landmark 1972 Roe v. Wade ruling, states are rushing either to protect abortion rights or pass laws intended to restrict or ban it.
Moderate to severe chronic liver disease can be predicted with the use of diffusion-weighted MRI (DWI), according to a recent study conducted by researchers at New York University Medical Center in New York, NY.
Older adults with type 1 diabetes typically have low blood sugar, or hypoglycemia, for more than an hour a day, suggests research to be presented Monday, March 25 at ENDO 2019, the annual meeting of the Endocrine Society, in New Orleans, La.
› Verified 6 days ago
Christopher Lowry Schaiberger, M.D. Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 500 University Dr, Hershey, PA 17033 Phone: 800-233-4082 | |
Kimberly S Harbaugh, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 30 Hope Dr Ste 1200, Hershey, PA 17033 Phone: 717-531-3828 Fax: 717-531-0793 | |
Haejoe Park, MD, MS Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 500 University Dr, Hershey, PA 17033 Phone: 800-243-1455 Fax: 717-531-0793 | |
Mark S Dias, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 500 University Dr, Hershey, PA 17033 Phone: 800-243-1455 | |
Steven J Schiff, M.D. Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 500 University Dr, Hershey, PA 17033 Phone: 800-233-4082 | |
Dr. Michael David Sather, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 30 Hope Dr Ste 1200, Hershey, PA 17033 Phone: 717-531-3828 Fax: 717-531-0793 | |
Joseph Christopher Zacko, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 30 Hope Dr, Ec110, Hershey, PA 17033 Phone: 717-531-0895 Fax: 717-531-3858 |